USD 2.1 billion
Report ID:
SQMIG30I2247 |
Region:
Global |
Published Date: March, 2025
Pages:
198
|Tables:
61
|Figures:
75
Fertility Supplements Market size was valued at USD 2.1 billion in 2023 and is poised to grow from USD 2.26 billion in 2024 to USD 4.09 billion by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).
The purpose of the fertility supplements market is to provide individuals with an alternative solution to improve their reproductive health and increase their chances of conceiving. The increasing prevalence of infertility is a major driving factor for the fertility supplements market. Additionally, rising awareness of the benefits of using dietary supplements to improve reproductive health and the availability of these supplements over the counter are also contributing to the growth of the market.
The lack of regulatory oversight and inconsistent product quality is a significant restraining factor for the fertility supplements market. Additionally, the high cost of some supplements may also limit their accessibility to some individuals. The absence of scientific proof demonstrating these supplements' ability to increase fertility is one of the major obstacles facing the market for fertility supplements. Furthermore, the stigma attached to infertility and some people's unwillingness to seek treatment could have an effect on the market's growth. It is anticipated that new market prospects would arise from the growing use of e-commerce platforms and the availability of a greater variety of fertility supplements. Furthermore, the growing popularity of customized nutrition and the creation of novel goods and formulas could propel market expansion. In the upcoming years, it is anticipated that the global market for fertility supplements would expand further as more people look for non-traditional ways to enhance their reproductive health.
The lack of regulatory oversight and inconsistent product quality is a significant restraining factor for the fertility supplements market. Additionally, the high cost of some supplements may also limit their accessibility to some individuals. The significant challenges faced by the fertility supplements market is the lack of scientific evidence supporting the effectiveness of these supplements in improving fertility. Moreover, the stigma associated with infertility and the reluctance of some individuals to seek treatment may also impact the market growth. The increasing adoption of e-commerce platforms and the availability of a wider range of fertility supplements is expected to create new opportunities in the market. Additionally, the growing trend of personalized nutrition and the development of new products and formulations may also stimulate market growth. The global fertility supplements market is expected to continue to grow in the coming years as more individuals seek alternative solutions to improve their reproductive health. The market faces several challenges that need to be addressed, including regulatory oversight and product quality, to ensure the safety and efficacy of these supplements.
US Fertility Supplements Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 2.1 billion
Largest Segment
Women
Fastest Growth
Men
Growth Rate
7.7% CAGR
To get more reports on the above market click here to Buy The Report
Global Fertility Supplements Market is segmented by Ingredient Type, Product, Distribution Channel, End User and region. Based on Ingredient Type, the market is segmented into Natural and Synthetic. Based on Product, the market is segmented into Capsules, Tablets, Soft gels, Powders and Liquids. Based on Distribution Channel, the market is segmented into OTC and Prescribed. Based on End User, the market is segmented into Men and Women. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
In 2022, the women segment dominated the global fertility supplements market with a share of over 55%. According to the Centers for Disease Control and Prevention, around 19% of women between the ages of 15 to 49 with no prior births suffer from infertility issues. The prevalence of fertility issues was found to be the highest among married infertile women aged 40 to 44, followed by women aged 35 to 39. The government and non-profit organizations' initiatives to provide advice and medical assistance have raised awareness and created opportunities for product manufacturers in the market. The men segment is projected to witness a CAGR of 9.6% during the forecast period. Male infertility can be caused by various factors, including hypogonadism, immune system factors, varicocele, systemic disease, sexual factors, undescended testicles, and urogenital infection. Men are solely responsible for about 20% of all infertility cases and are contributing factors in another 30% to 40% of cases. According to a paper published in the National Library of Medicine in 2022, the male factor significantly contributes to about 50% of all infertility cases. This is expected to drive product demand in this segment over the forecast period.
In 2022, the largest share of over 75% in the global fertility supplements market was held by the over-the-counter (OTC) distribution channel segment. The market is highly competitive due to the increasing demand, easy availability of raw materials, and lenient regulations. To succeed in this market, companies must focus on incorporating FDA-regulated ingredients that have undergone a significant number of clinical trials or studies. Self-medication for the treatment of fertility issues is a key trend in the OTC segment. Moreover, cost-effectiveness and the convenience of direct purchase are expected to create opportunities for OTC fertility supplement manufacturers in the near future. The prescribed segment is projected to expand at a lucrative CAGR of 10.8% from 2022 to 2030. The demand for prescribed fertility supplements is expected to increase due to stringent regulations by governing bodies in some regions, lack of certainty regarding the efficacy of products not prescribed by a medical professional, and lower awareness among individuals. Moreover, increasing R&D expenditure, coupled with funding from public and private sectors, is expected to boost the demand for prescribed fertility supplements over the forecast period.
To get detailed analysis on other segments, Request For Free Sample Report
North America held the largest share in the global fertility supplements market. Data from the Centers for Disease Control and Prevention (CDC) update indicated that 14.1% of women aged 15 to 49 in the U.S. had impaired fertility, while 15.1% of married women aged 15 to 49 had impaired fertility. In addition, 7% of married women were found to be infertile, which has increased the demand for fertility products in the region. Furthermore, the market in Canada is expected to grow rapidly due to initiatives by the government and nonprofit organizations such as Fertility Matters Canada to raise awareness about fertility medication and treatment, as well as the rising rates of obesity and sexually transmitted infections.
Asia Pacific is expected to experience significant growth in the fertility supplement market, with a projected CAGR of 12.0% from 2022 to 2030. The region offers promising opportunities for leading companies due to increased accessibility and availability of healthcare facilities, as well as increased expenditure in the research and healthcare sectors. Rising awareness about nutritional enrichment in India and China is expected to be a significant factor for regional growth. Additionally, the retail market is expected to expand in countries such as India, China, Indonesia, and Malaysia due to regulatory support to encourage investment, which will increase buyer accessibility and help the market grow in the region.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Fertility Supplements Market Drivers
The effects of smoking, drinking, and caffeine on fertility
The rapidly expanding health and wellness sector
Fertility Supplements Market Restraints
Lack of Scientific Evidence
Increase in the desire for IVF, sperm and egg freezing, and surrogacy
Request Free Customization of this report to help us to meet your business objectives.
The global fertility supplements market is highly competitive in nature with the presence of various key players. The market is fragmented due to the presence of numerous local and international players, and the high degree of competition is leading to continuous innovation, development, and launching of new products. The competitive landscape of the global fertility supplements market is expected to remain intense, with companies focusing on product innovation, strategic partnerships, and mergers and acquisitions to gain a competitive advantage.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global fertility supplements market analysis, the market is expected to grow at a significant pace over the forecast period of 2023 to 2030. The market growth can be attributed to various factors such as rising infertility rates, changing lifestyles, increasing awareness about fertility supplements, and advancements in medical research and technology. The competitive landscape of the global fertility supplements market is highly fragmented, with the presence of both established players and new entrants. The global fertility supplements market is expected to witness significant growth in the coming years, driven by various factors such as rising infertility rates, increasing awareness about fertility supplements, and advancements in medical research and technology.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 2.1 billion |
Market size value in 2032 | USD 4.09 billion |
Growth Rate | 7.7% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Fertility Supplements Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Fertility Supplements Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Fertility Supplements Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Fertility Supplements Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Fertility Supplements Market size was valued at USD 2.1 Billion in 2023 and is poised to grow from USD 2.27 Billion in 2024 to USD 4.19 Billion by 2032, growing at a CAGR of 8% during the forecast period (2025-2032).
The global fertility supplements market is highly competitive in nature with the presence of various key players. The market is fragmented due to the presence of numerous local and international players, and the high degree of competition is leading to continuous innovation, development, and launching of new products. The competitive landscape of the global fertility supplements market is expected to remain intense, with companies focusing on product innovation, strategic partnerships, and mergers and acquisitions to gain a competitive advantage. 'TTK HealthCare (India)', 'Fairhaven Health LLC (U.S.)', 'Zenith Nutritions (India)', 'INVO Bioscience (U.S.)', 'Vitabiotics Ltd (U.K.)', 'Bionova Lifesciences (India)', 'Exeltis USA Inc. (U.S.)', 'Fujifilm Irvine Scientific, Inc. (U.S.)', 'Coast Science (U.S.)', 'Orthomol (Germany)', 'Theralogix LLC (U.S.)', 'Mira (U.S.)', 'Proxeed Plus (U.S.)', 'Fertility Nutraceuticals LLC (U.S.)', 'Fertility Focus Limited (U.K.)', 'DCC plc (Ireland)', 'Purelife Bioscience Co. Ltd. (Taiwan)', 'Fertility Smart (Australia)', 'Concepta Diagnostics (U.K.)', 'TTK Prestige Ltd (India)'
Fertility Supplements Market Drivers
Increasing demand for natural and organic supplements: Consumers are increasingly opting for natural and organic fertility supplements as they are perceived to be safer and have fewer side effects. These supplements are made from natural ingredients such as herbs, vitamins, and minerals, and do not contain any synthetic substances. For instance, In folic, a natural supplement made from myo-inositol and folic acid, has gained popularity in the market due to its natural composition and effectiveness in promoting fertility.
North America held the largest share in the global fertility supplements market. Data from the Centers for Disease Control and Prevention (CDC) update indicated that 14.1% of women aged 15 to 49 in the U.S. had impaired fertility, while 15.1% of married women aged 15 to 49 had impaired fertility. In addition, 7% of married women were found to be infertile, which has increased the demand for fertility products in the region. Furthermore, the market in Canada is expected to grow rapidly due to initiatives by the government and nonprofit organizations such as Fertility Matters Canada to raise awareness about fertility medication and treatment, as well as the rising rates of obesity and sexually transmitted infections.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG30I2247
[email protected]
USA +1 351-333-4748